Evidence map›Paper›PMID 41239267›Full record

ArticleBMC infectious diseases2025

Streptococcus dysgalactiae subsp. equisimilis bacteremia in Finland: changes in emm-type distribution combined with clinical presentation.

Viivi Nevanlinna, Janne Aittoniemi, Reetta Huttunen, Hanne-Leena Hyyryläinen, Tapio Seiskari, Tiina Luukkaala, Sari Rantala

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Viivi NevanlinnaDepartment of Internal Medicine, Tampere University Hospital, Tampere, Finland. viivi.nevanlinna@tuni.fi.
Janne AittoniemiFimlab Laboratories, Tampere, Finland.
Reetta HuttunenDepartment of Internal Medicine, Tampere University Hospital, Tampere, Finland.
Hanne-Leena HyyryläinenPublic Health, Finnish Institute for Health and Welfare, Microbiology, Helsinki, Finland.
Tapio SeiskariFimlab Laboratories, Tampere, Finland.
Tiina LuukkaalaResearch, Development and Innovation Center, Tampere University Hospital, Tampere, Finland.
Sari RantalaDepartment of Internal Medicine, Tampere University Hospital, Tampere, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe incidence of SDSE bacteremia has risen dramatically over the past two decades, but it is unclear whether this increase is influenced by changes in the emm types of SDSE isolates. Furthermore, the relationships between emm types and clinical manifestations or disease severity are poorly understood.

methodsWe conducted a retrospective, population-based study of emm types in SDSE bacteremia episodes in the Pirkanmaa health district from August 2015 to June 2018 and compared the findings to data from the same geographic area collected between 1995 and 2004.

resultsDuring the study period, 230 episodes of SDSE bacteremia were identified. The most common emm types were stG480, stG485, and stG6, consistent with findings from the same geographic area 20 years ago. The most notable change in emm type distribution was the emergence of stG62647 as the third most common emm type, along with stG6. Despite changes in distribution, the incidence rates of isolates of all emm types identified in this study have significantly increased compared with the study conducted 1995 to 2004. Emm type StC74a was associated with higher mortality rates (OR 4.088 [95% CI 1.177-14.202]). Skin and soft-tissue infections were less common with stG485 (OR 0.455 [95% CI 0.207-1.000]), and the infection focus was more often unknown (OR 3.395 [95% CI 1.375-8.382]). StG480 was associated with arthritis (OR 5.147 [95% CI 1.227-21.589]).

conclusionsThe increase in SDSE bacteremia is driven by both the rise of formerly common emm types and the newly emerged strain stG62647.

Indexed as

Antigens, BacterialBacteremiaBacterial Outer Membrane ProteinsCarrier ProteinsStreptococcal InfectionsStreptococcusAdolescentAdultAgedAged, 80 and overChildChild, PreschoolFemaleFinlandHumansIncidenceAntigens, BacterialBacterial Outer Membrane ProteinsCarrier Proteinsstreptococcal M proteinStreptococcus dysgalactiae subspecies equisimilis; SDSE; Bacteremia; Emmtype

Identifiers

PMID41239267
PMCPMC12619355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.